.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Chinese Patent Office
Daiichi Sankyo
Julphar
Novartis
Express Scripts
Citi
Cantor Fitzgerald
Boehringer Ingelheim

Generated: September 24, 2017

DrugPatentWatch Database Preview

ATAZANAVIR SULFATE Drug Profile

« Back to Dashboard

What is the patent landscape for Atazanavir Sulfate, and when can generic versions of Atazanavir Sulfate launch?

Atazanavir Sulfate is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in ATAZANAVIR SULFATE is atazanavir sulfate. There are twenty-three drug master file entries for this compound. Five suppliers are listed for this compound. There are seven tentative approvals for this compound. Additional details are available on the atazanavir sulfate profile page.

Summary for Tradename: ATAZANAVIR SULFATE

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list36
Clinical Trials: see list827
Patent Applications: see list22
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATAZANAVIR SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
ATAZANAVIR SULFATE
atazanavir sulfate
CAPSULE;ORAL091673-001Apr 22, 2014RXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ATAZANAVIR SULFATE
atazanavir sulfate
CAPSULE;ORAL091673-004Apr 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ATAZANAVIR SULFATE
atazanavir sulfate
CAPSULE;ORAL091673-002Apr 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ATAZANAVIR SULFATE
atazanavir sulfate
CAPSULE;ORAL091673-003Apr 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Covington
Johnson and Johnson
Colorcon
AstraZeneca
Deloitte
Federal Trade Commission
US Department of Justice
Mallinckrodt
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot